| Mathematics and Statistics | Lifetime | 333 | JP 3 | 99.41 |
| Mathematics and Statistics | 2021-2025 | 208 | JP 3 | 98.44 |
| Modeling and Simulation | Lifetime | 31 | JP 1 | 99.45 |
| Epidemiology | Lifetime | 828 | JP 22 | 98.89 |
| Infectious Diseases | Lifetime | 349 | JP 2 | 98.74 |
| Virology | Lifetime | 612 | JP 6 | 73.50 |
| Modeling and Simulation | 2021-2025 | 68 | JP 1 | 97.82 |
| Infectious Diseases | 2021-2025 | 204 | JP 3 | 96.52 |
| Epidemiology | 2021-2025 | 663 | JP 18 | 93.80 |
| COVID-19 epidemiological studies | Lifetime | 57 | JP 3 | 99.33 |
| COVID-19 Pandemic Impacts | Lifetime | 30 | JP 3 | 99.10 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 255 | JP 4 | 99.01 |
| Influenza Virus Research Studies | Lifetime | 162 | JP 5 | 99.06 |
| COVID-19 Clinical Research Studies | Lifetime | 434 | JP 5 | 98.27 |
| Viral Infections and Outbreaks Research | Lifetime | 98 | JP 5 | 98.89 |
| Zoonotic diseases and public health | Lifetime | 112 | JP 1 | 98.21 |
| SARS-CoV-2 detection and testing | Lifetime | 188 | JP 8 | 96.29 |
| Data-Driven Disease Surveillance | Lifetime | 93 | JP 2 | 97.19 |
| Viral Infections and Vectors | Lifetime | 639 | JP 17 | 98.13 |
| Respiratory viral infections research | Lifetime | 667 | JP 18 | 97.74 |
| Bacillus and Francisella bacterial research | Lifetime | 195 | JP 2 | 96.59 |
| Disaster Response and Management | Lifetime | 332 | JP 6 | 96.29 |
| Animal Disease Management and Epidemiology | Lifetime | 776 | JP 52 | 96.51 |
| Poxvirus research and outbreaks | Lifetime | 223 | JP 3 | 95.52 |
| Virology and Viral Diseases | Lifetime | 773 | JP 38 | 94.92 |
| Phagocytosis and Immune Regulation | Lifetime | 514 | JP 30 | 93.04 |
| Yersinia bacterium, plague, ectoparasites research | Lifetime | 635 | JP 12 | 92.93 |
| COVID-19 Digital Contact Tracing | Lifetime | 56 | JP 1 | 86.53 |
| Infection Control and Ventilation | Lifetime | 571 | JP 12 | 90.82 |
| Mathematical and Theoretical Epidemiology and Ecology Models | Lifetime | 897 | JP 29 | 91.88 |
| Travel-related health issues | Lifetime | 521 | JP 6 | 86.02 |
| COVID-19 epidemiological studies | 2021-2025 | 130 | JP 3 | 97.79 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 670 | JP 19 | 97.35 |
| SARS-CoV-2 detection and testing | 2021-2025 | 248 | JP 9 | 94.90 |
| COVID-19 Pandemic Impacts | 2021-2025 | 155 | JP 3 | 94.88 |
| Data-Driven Disease Surveillance | 2021-2025 | 85 | JP 2 | 90.01 |
| Herpesvirus Infections and Treatments | 2021-2025 | 464 | JP 7 | 85.34 |
| Viral Infections and Outbreaks Research | 2021-2025 | 530 | JP 17 | 84.82 |
| COVID-19 Digital Contact Tracing | 2021-2025 | 54 | JP 1 | 80.66 |
| Zoonotic diseases and public health | 2021-2025 | 453 | JP 3 | 82.43 |
| Virology and Viral Diseases | 2021-2025 | 426 | JP 10 | 78.74 |
| Travel-related health issues | 2021-2025 | 154 | JP 2 | 74.44 |
